Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study.

Gattu S, Busse K, Bhutani T, Chiang C, Nguyen T, Becker E, Koo JY.

J Dermatolog Treat. 2012 Apr;23(2):103-8. doi: 10.3109/09546634.2010.500323. Epub 2011 Jan 22.

PMID:
21254875
2.

Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study.

Bhutani T, Kamangar F, Zitelli K, Chiang C, Gattu S, Nguyen T, Becker E, Koo J.

J Dermatolog Treat. 2013 Oct;24(5):348-50. doi: 10.3109/09546634.2012.672712. Epub 2012 Jun 5.

PMID:
22506829
3.

Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.

Huang PH, Liao YH, Wei CC, Tseng YH, Ho JC, Tsai TF.

J Eur Acad Dermatol Venereol. 2008 Aug;22(8):923-30. doi: 10.1111/j.1468-3083.2007.02575.x. Epub 2008 Feb 27.

PMID:
18312328
4.

The safety and efficacy of high-dose alefacept compared with a loading dose of alefacept in patients with chronic plaque psoriasis.

Cafardi JA, Cantrell W, Wang W, Elmets CA, Elewski BE.

Skinmed. 2008 Mar-Apr;7(2):67-72.

PMID:
18327010
5.
6.

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group.

Arch Dermatol. 2003 Jun;139(6):719-27.

PMID:
12810502
7.
9.

An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.

Ortonne JP, Khemis A, Koo JY, Choi J.

J Eur Acad Dermatol Venereol. 2005 Sep;19(5):556-63.

PMID:
16164708
10.

Alefacept.

Frampton J, Wagstaff A.

Am J Clin Dermatol. 2003;4(4):277-86; discussion 287. Review.

PMID:
12680805
11.

A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.

Lui H, Gulliver W, Tan J, Hong CH, Hull P, Shear NH, Paradiso-Hardy F, Bissonette R.

J Drugs Dermatol. 2012 Aug;11(8):929-37.

PMID:
22859237
13.

The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis.

Roberts JL, Ortonne JP, Tan JK, Jaracz E, Frankel E; Alefacept Clinical Study Group.

J Am Acad Dermatol. 2010 Jun;62(6):968-78. doi: 10.1016/j.jaad.2009.07.032. Epub 2010 Apr 14.

PMID:
20392521
14.

An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis.

Gribetz CH, Blum R, Brady C, Cohen S, Lebwohl M.

J Am Acad Dermatol. 2005 Jul;53(1):73-5.

PMID:
15965424
15.

Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series.

Shah A, O'Neill J, Feldman SR.

J Drugs Dermatol. 2010 Dec;9(12):1491-4.

PMID:
21120256
16.

Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study.

Mease PJ, Reich K; Alefacept in Psoriatic Arthritis Study Group.

J Am Acad Dermatol. 2009 Mar;60(3):402-11. doi: 10.1016/j.jaad.2008.09.050. Epub 2008 Nov 25. Erratum in: J Am Acad Dermatol. 2009 Sep;61(3):507.

PMID:
19028407
17.

Remittive effects of intramuscular alefacept in psoriasis.

Gordon KB, Langley RG.

J Drugs Dermatol. 2003 Dec;2(6):624-8.

PMID:
14711140
18.

An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis.

Krell J, Nelson C, Spencer L, Miller S.

J Am Acad Dermatol. 2008 Apr;58(4):609-16. doi: 10.1016/j.jaad.2007.12.031. Epub 2008 Feb 11.

PMID:
18262681
19.

Development and use of alefacept to treat psoriasis.

Krueger GG, Callis KP.

J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S87-97. Review.

PMID:
12894131
20.

Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.

Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC.

Arch Dermatol Res. 2007 Feb;298(9):457-63. Epub 2006 Nov 30.

PMID:
17136563

Supplemental Content

Support Center